APA (7th ed.) Citation

Munarriz, D., López-Godino, O., Martinez-Cibrian, N., Albiol, N., Brillembourg, H., Navarro-Velázquez, S., . . . Montoro-Lorite, M. (2025). Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. International Journal of Molecular Sciences, 26(19), 9265. https://doi.org/10.3390/ijms26199265

Chicago Style (17th ed.) Citation

Munarriz, Daniel, et al. "Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report." International Journal of Molecular Sciences 26, no. 19 (2025): 9265. https://doi.org/10.3390/ijms26199265.

MLA (9th ed.) Citation

Munarriz, Daniel, et al. "Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report." International Journal of Molecular Sciences, vol. 26, no. 19, 2025, p. 9265, https://doi.org/10.3390/ijms26199265.